NovoCure Limited financials

NVCR CIK 0001645113

Source: EDGAR filings · Built 2026-06-02T03:41:57Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -75.68M -69.22M -100.43M 9.43M 58.59M 84.18M
EBITDA -139.15M -159.26M -221.90M -78.90M -34.08M 39.55M
Working Capital 423.50M 350.18M 855.29M 952.75M 930.92M 885.83M
Net Debt 154.81M 422.27M 363.64M 474.75M 373.10M 216.01M
Gross Margin 74.54% 77.33% 74.81% 78.64% 78.53% 78.46%
Operating Margin -23.47% -28.17% -45.72% -16.64% -8.29% 6.15%
Net Margin -20.79% -27.86% -40.65% -17.20% -10.91% 4.01%
Return on Equity (ROE) -40.01% -46.82% -57.12% -20.97% -14.21% 4.16%
Return on Assets (ROA) -16.94% -13.59% -18.06% -7.77% -5.12% 1.88%
Current Ratio 2.90× 1.46× 5.78× 7.00× 7.53× 8.80×
Debt-to-Equity 0.73× 1.63× 1.67× 1.34× 1.42× 0.95×
Effective Tax Rate 0.02% -28.56% -7.98% -13.06% -12.05% -9.42%
Cash Conversion Ratio 0.36× 0.16× 0.35× -0.33× -1.42× 5.01×
Accruals Ratio -0.11× -0.11× -0.12× -0.10× -0.12× -0.08×
SBC % of Revenue 16.00% 26.44% 22.70% 19.89% 17.74% 15.32%
CapEx Coverage -1.84× -0.62× -2.71× 1.44× 3.42× 6.62×
Free Cash Flow Per Share $-0.68 $-0.64 $-0.94 $0.09 $0.57 $0.77

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 961.33×
P/FCF 814.10× 132.56× 223.80×
FCF Yield 0.12% 0.75% 0.45%
EV / EBITDA 453.19×
P/S 2.22× 5.34× 3.14× 14.33× 14.59× 35.82×
P/B 4.27× 8.98× 4.41× 17.47× 19.02× 37.16×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 655.35M 605.22M 509.34M 537.84M 535.03M 494.37M
Cost of Revenue 166.88M 137.18M 128.28M 114.87M 114.88M 106.50M
Gross Profit 488.47M 468.04M 381.06M 422.97M 420.15M 387.87M
Research and Development Expense 224.54M 209.65M 223.06M 206.09M 201.30M 132.01M
Operating Expenses 642.27M 638.53M 613.93M 512.50M 464.49M 357.46M
Operating Income (Loss) -153.80M -170.50M -232.87M -89.52M -44.33M 30.40M
Income Tax Expense (Benefit) -23.00K 37.47M 15.30M 10.69M 6.28M -1.71M
Net Income (Loss) Attributable to Parent -136.23M -168.63M -207.04M -92.53M -58.35M 19.81M
Earnings Per Share, Basic $-1.22 $-1.56 $-1.95 $-0.88 $-0.56 $0.20
Weighted Average Number of Shares Outstanding, Basic 111.47M 107.83M 106.39M 104.66M 103.43M 100.93M
Earnings Per Share, Diluted $-1.22 $-1.56 $-1.95 $-0.88 $-0.56 $0.18
Weighted Average Number of Shares Outstanding, Diluted 111.47M 107.83M 106.39M 104.66M 103.43M 108.88M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 93.55M 163.77M 240.82M 115.33M 208.80M 234.67M
Assets, Current 646.73M 1.11B 1.03B 1.11B 1.07B 999.44M
Assets 804.33M 1.24B 1.15B 1.19B 1.14B 1.05B
Long-term Debt 568.82M 565.51M 562.22M 429.90M
Liabilities, Current 223.23M 756.39M 179.12M 158.78M 142.60M 113.61M
Long-term Debt, Excluding Current Maturities 195.05M 97.30M 568.82M 565.51M 562.22M 429.90M
Liabilities 463.86M 880.61M 783.63M 750.48M 729.00M 575.46M
Stockholders' Equity Attributable to Parent 340.47M 360.18M 362.50M 441.17M 410.49M 476.53M
Common Stock, Shares, Outstanding 112.49M 108.52M 107.08M 105.05M 103.97M 102.33M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -49.03M -26.37M -73.34M 30.79M 82.76M 99.15M
Payments to Acquire Property, Plant, and Equipment 26.65M 42.85M 27.09M 21.36M 24.17M 14.97M
Net Cash Provided by (Used in) Investing Activities 437.28M -140.24M 184.15M -139.96M -144.83M -472.85M
Net Cash Provided by (Used in) Financing Activities -451.34M 90.31M 15.79M 15.49M 25.70M 440.21M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NVCR CIK 0001645113), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ECL

ECOLAB INC.

NN

NextNav Inc.

WAL

WESTERN ALLIANCE BANCORPORATION